Results 221 to 230 of about 20,284 (260)
Some of the next articles are maybe not open access.
Surgical Ablation of Ventricular Tachycardia
Cardiac Electrophysiology Clinics, 2022Surgery for ventricular tachycardia (VT) is indicated in patients in whom pharmacotherapy or catheter ablation is ineffective or frequent VT attacks are not suppressed or with frequent activation of implantable cardioverter defibrillator. In ischemic VT, resection of fibrous endocardium combined with encircling cryothermia at the border between the ...
openaire +2 more sources
Ablation of ventricular fibrillation and tachycardia
Current Cardiology Reports, 2005Catheter ablation therapy for ventricular tachycardia has evolved over the past 20 years to become the first-line therapy. This development has been facilitated by technology that has allowed better anatomic and electrophysiologic correlations. A better understanding of radiofrequency (RF) ablation has led to safer and more effective treatments ...
Paveljit S, Bindra +1 more
openaire +2 more sources
Catheter ablation of ventricular tachycardia
Current Opinion in Cardiology, 1995Endocardial lesions created by radiofrequency catheter ablation are relatively small and focal. The application of radiofrequency ablation to patients with structural heart disease and ventricular tachycardia is quite limited because the substrate for these tachycardias is often diffuse or difficult to localize.
E, Daoud, F, Morady
openaire +2 more sources
Catheter ablation of ventricular tachycardia
Current Treatment Options in Cardiovascular Medicine, 2003Most patients with ventricular tachycardia (VT) associated with structural heart disease should receive an implantable cardioverter-defibrillator as initial therapy. Patients with symptomatic recurrences of tachycardia, including those with multiple defibrillator shocks, are considered for ablation.
Sean P., Tierney, David J., Wilber
openaire +2 more sources
Catheter ablation of ventricular tachycardia
American Heart Journal, 1994The role and success rate of catheter ablation for monomorphic ventricular tachycardia (VT) depend on the mechanism and origin of the tachycardia (i.e., myocardial versus His-Purkinje system) and whether it occurs in the presence or absence of structural heart diseases.
Z, Blanck +5 more
openaire +2 more sources
Ablation of Idiopathic Ventricular Tachycardia
Current Cardiology Reports, 2010Idiopathic ventricular arrhythmias occur in patients without structural heart disease. They can arise from a variety of specific areas within both ventricles and in the supravalvular regions of the great arteries. Two main groups need to be differentiated: arrhythmias from the outflow tract (OT) region and idiopathic left ventricular, so-called ...
Doreen, Schreiber, Hans, Kottkamp
openaire +2 more sources
Ventricular Tachycardia Ablation
Anesthesia & Analgesia, 2015Percutaneous catheter ablation is being increasingly performed in patients with recurrent ventricular tachycardia (VT) unresponsive to medical treatment. Optimal management of patients requires careful consideration of the severity of the underlying cardiac disease, the anesthetic drug interactions, and the procedural technique during VT mapping and ...
Alexander J C, Mittnacht +2 more
openaire +2 more sources
Catheter Ablation for Ventricular Tachycardia
New England Journal of MedicineN ...
openaire +5 more sources
[Catheter ablation of ventricular tachycardias].
Orvosi hetilap, 2015Catheter ablation of ventricular tachycardias emerged significantly as standard therapy in the past 20 years. In this review recent advances in catheter ablation of ventricular tachycardias are discussed. The authors first present in details the technical aspects of ablation strategies, main indications and contraindications of ventricular tachycardia ...
Mihalcz, A, Szili Torok, Tamas, Toth, K
openaire +2 more sources
Ventricular Tachycardia Ablation Clinical Trials
Cardiac Electrophysiology Clinics, 2017Catheter ablation is an increasingly used treatment option for patients with ventricular tachycardia (VT) in the setting of structural heart disease. Although there are extensive data from several retrospective studies as well as prospective nonrandomized observational studies, there are limited data from relatively few randomized controlled trials ...
Jackson J, Liang +2 more
openaire +2 more sources